Cargando…

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis

BACKGROUND: Depressive symptoms occur in several psychiatric disorders, often in the absence of a formal diagnosis of depression. We aimed to evaluate the efficacy and the tolerability of amisulpride, both alone and as augmentation therapy, in the treatment of depressive symptoms in individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zangani, Caroline, Giordano, Barbara, Stein, Hans‐Christian, Bonora, Stefano, D'Agostino, Armando, Ostinelli, Edoardo Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596405/ https://www.ncbi.nlm.nih.gov/pubmed/34727399 http://dx.doi.org/10.1002/hup.2801

Ejemplares similares

Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study
por: D’Agostino, Armando, et al.
Publicado: (2022)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis
por: Ostinelli, Edoardo G, et al.
Publicado: (2019)

Evaluation of telepsychiatry during the COVID-19 pandemic across service users, carers and clinicians: an international mixed-methods study
por: Sheriff, Rebecca, et al.
Publicado: (2023)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
por: Kumar, Subodh, et al.
Publicado: (2014)

Amisulpride Augmentation for Clozapine-Refractory Positive Symptoms: Additional Benefit in Reducing Hypersialorrhea
por: Bogorni, Fabiani, et al.
Publicado: (2015)

The use of amisulpride in the treatment of acute psychosis
por: Nuss, Philippe, et al.
Publicado: (2007)

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

Delayed-onset akathisia due to amisulpride
por: Atmaca, Murad, et al.
Publicado: (2011)

Treatment of Burning Mouth Syndrome With Amisulpride
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

S6. SLEEP ENDOPHENOTYPES OF SCHIZOPHRENIA: A HIGH-DENSITY EEG STUDY IN DRUG-NAïVE, FIRST EPISODE PSYCHOSIS PATIENTS
por: Castelnovo, Anna, et al.
Publicado: (2020)

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets
por: Yuan, Bozhi, et al.
Publicado: (2022)

The use of amisulpride in schizophrenic patients with resistant symptomatology
por: Kalfas, Dimitrios, et al.
Publicado: (2010)

Ejaculatory dysfunction associated with low dose amisulpride
por: Nagapurkar, Umesh, et al.
Publicado: (2013)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Amisulpride withdrawal dyskinesia: a case report
por: Lo, Yu-Chi, et al.
Publicado: (2017)

Retracted: Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets
por: Methods in Medicine, Computational and Mathematical
Publicado: (2022)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
por: Liang, Ying, et al.
Publicado: (2017)

Development and validation of a meta-learner for combining statistical and machine learning prediction models in individuals with depression
por: Liu, Qiang, et al.
Publicado: (2022)

COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services
por: Ostinelli, Edoardo G., et al.
Publicado: (2022)

Augmenting amisulpride with clozapine had led to unmasking of akathisia
por: Ray, Anirban, et al.
Publicado: (2012)

Priapism secondary to antipsychotic treatments with favorable response to amisulpride
por: Pérez Balaguer, A., et al.
Publicado: (2022)

Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study
por: Zheng, Jinchi, et al.
Publicado: (2022)

Analysis of Amisulpride in Human Plasma by SPE and LC with Fluorescence Detection
por: Kudris, Illia V., et al.
Publicado: (2011)

Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis
por: Peritogiannis, Vaios, et al.
Publicado: (2010)

Pulmonary Embolism Related to Amisulpride Treatment: A Case Report
por: Skokou, Maria, et al.
Publicado: (2013)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
por: Abdall-Razak, Ali, et al.
Publicado: (2019)

Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial
por: Zhu, Cuifang, et al.
Publicado: (2022)

Schizophrenia: from neurophysiological abnormalities to clinical symptoms
por: Castelnovo, Anna, et al.
Publicado: (2015)

Vitruvian plot: a visualisation tool for multiple outcomes in network meta-analysis
por: Ostinelli, Edoardo Giuseppe, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on the Global Delivery of Mental Health Services and Telemental Health: Systematic Review
por: Zangani, Caroline, et al.
Publicado: (2022)

Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers
por: Fox, Gabriel M, et al.
Publicado: (2019)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Title- Augmenting Amisulpride With Clozapine Leading To Akathisia: A Case Report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5e7lruk5r9suvg4rc425uokq6s